Next generation sequencing identifies an increased diversity of microbes in post lavage specimens in infected TKA using a biofilm disrupting irrigant
The Knee · 2024
DOI: 10.1016/j.knee.2024.09.010 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Knee, 2024. Verfasst von Madhav Chowdhry und 5 weiteren Autor:innen. Beteiligte Einrichtung: Nuffield Department of Primary Care Health Sciences & Department of Continuing Education, Kellogg College, University of Oxford, UK. Electronic addre…. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Knee, Prosthesis-Related Infections, Biofilms, Therapeutic Irrigation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Periprosthetic joint infection (PJI) is a devastating complication of joint arthroplasty. In chronic PJI, a biofilm envelops the surface of implants, which contains microbiota within an extra-microbial polymeric matrix (EMPM). Microbial identification is paramount for effective treatment. In this study, we use a multi-modal, EMPM disrupting, neoadjuvant irrigant and compare the microbiota detected pre-lavage to post-lavage by two techniques: culture and Next Generation Sequencing (NGS). We suspect more organisms to be identified after applying an EMPM disrupting irrigant. METHODS: A multicenter, prospective study was conducted on 38 patients with known Total Knee Arthroplasty PJI. At initial arthrotomy, synovial fluid was obtained and analyzed for quantitative cultures and microbial NGS. Joint was then irrigated with Bactisure Lavage followed by Normal Saline. Post-lavage samples were similarly obtained and analyzed. RESULTS: In pre-lavage samples for cultures, 55.3% of samples were positive, identifying 11 unique organisms. In post-lavage samples for cultures, 13.2% of samples were positive, identifying 5 unique organisms. In pre-lavage samples for NGS, 79% were DNA signal positive, identifying 126 unique organisms. In post-lavage samples for NGS, 74% of samples were DNA signal positive, identifying 177 unique organisms. Moreover, 135/177 of these organisms were not identified pre-lavage. CONCLUSION: In this pre-to-post irrigant study, culture showed a decrease in the number of identifiable organisms post-lavage. In contrast NGS revealed an increase in the number of identifiable organisms post-lavage. Furthermore, NGS identified 135 additional organisms, not detected pre-lavage. This suggests an increased diversity of microbes may exist within EMPM, which are not cultivable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nuffield Department of Primary Care Health Sciences & Department of Continuing Education, Kellogg College, University of Oxford, UK. Electronic address: Madhav.chowdhry@gmail.com.
- David Geffen School of Medicine, UCLA, Dept. of Orthopaedic Surgery, Los Angeles, USA.
- University of Kentucky College of Medicine, Department of Orthopaedic Surgery 125 E. Maxwell Street, Suite 201, Lexington, KY 40508, USA.
Zitieren
APA
Chowdhry, M., Dipane, M. V., Duncan, S. T., Pena, D., Stavrakis, A., & McPherson, E. J. (2024). Next generation sequencing identifies an increased diversity of microbes in post lavage specimens in infected TKA using a biofilm disrupting irrigant. The Knee. https://doi.org/10.1016/j.knee.2024.09.010
Vancouver
Chowdhry M, Dipane MV, Duncan ST, Pena D, Stavrakis A, McPherson EJ. Next generation sequencing identifies an increased diversity of microbes in post lavage specimens in infected TKA using a biofilm disrupting irrigant. The Knee. 2024. doi:10.1016/j.knee.2024.09.010
BibTeX
@article{Chowdhry2024,
author = {Chowdhry, Madhav and Dipane, Matthew V and Duncan, Stephen T and Pena, Diego and Stavrakis, Alexandra and McPherson, Edward J},
title = {Next generation sequencing identifies an increased diversity of microbes in post lavage specimens in infected TKA using a biofilm disrupting irrigant},
journal = {The Knee},
year = {2024},
doi = {10.1016/j.knee.2024.09.010}
}
EUVIMED